Ye Weiguo 4
4 · GYRE THERAPEUTICS, INC. · Filed Mar 11, 2025
Insider Transaction Report
Form 4
Ye Weiguo
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-07+300,000→ 300,000 totalExercise: $10.32Exp: 2035-03-07→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 300,000 shares of the Issuer's common stock and will vest in 48 equal monthly installments through March 7, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date.